Resolution of P‐glycoprotein and non‐P‐glycoprotein effects on drug permeability using intestinal tissues from mdr1a (−/−) mice
Open Access
- 1 April 2002
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 135 (8) , 2038-2046
- https://doi.org/10.1038/sj.bjp.0704668
Abstract
Intestinal xenobiotic transporters are a significant barrier to the absorption of many orally administered drugs. P‐glycoprotein (PGP) is the best known, but several others, including members of the multidrug resistance‐associated protein (MRP) family, are also expressed. Definitive information on their precise effect on intestinal drug permeability is scarce due to a lack of specific inhibitors and the difficulty of studying non‐PGP activity in the presence of high PGP expression. We have investigated the in vitro use of intestinal tissues from PGP knockout (mdr1a (−/−)) mice as a tool for dissecting the mechanisms of intestinal drug efflux. The permeability characteristics of digoxin (DIG), paclitaxel (TAX) and etoposide (ETOP) were measured in ileum from mdr1a (−/−) and wild‐type (FVB) mice mounted in Ussing chambers. DIG and TAX exhibited marked efflux across FVB tissues (B‐A : A‐B apparent permeability (Papp) ratio 10 and 17 respectively) which was absent in mdr1a (−/−) tissues, confirming that PGP is the sole route of intestinal efflux for these compounds. The A‐B Papp of both compounds was 3 – 5 fold higher in mdr1a (−/−) than in FVB. Polarized transport of ETOP in FVB tissues was reduced but not abolished in mdr1a (−/−) tissues. Residual ETOP efflux in mdr1a (−/−) tissues was abolished by the MRP inhibitor MK571, indicating involvement of both PGP and MRP. MK571 abolished calcein efflux in mdr1a (−/−) tissues, while quinidine had no parallel effect in FVB tissues, suggesting involvement of MRP but not PGP. Tissues from mdr1a (−/−) mice provide a novel approach for investigating the influence of PGP ablation on intestinal permeability and for resolving PGP and non‐PGP mechanisms that modulate drug permeability. British Journal of Pharmacology (2002) 135, 2038–2046; doi:10.1038/sj.bjp.0704668Keywords
This publication has 41 references indexed in Scilit:
- Calcein accumulation as a fluorometric functional assay of the multidrug transporterPublished by Elsevier ,2002
- Active transport of the angiotensin‐II antagonist losartan and its main metabolite EXP 3174 across MDCK‐MDR1 and Caco‐2 cell monolayersBritish Journal of Pharmacology, 2000
- Role of P‐glycoprotein‐mediated secretion in absorptive drug permeabiity: An approach using passive membrane permeability and affinity to P‐glycoprotein††Dedicated to Prof. B. C. Lippold on the occasion of his 60th birthday.Journal of Pharmaceutical Sciences, 1999
- Membrane Transport of Drugs in Different Regions of the Intestinal Tract of the RatJournal of Pharmaceutical Sciences, 1998
- Calcein is excreted from the intestinal mucosal cell membrane by the active transport systemLife Sciences, 1996
- The Multidrug Resistance‐associated Protein Gene Confers Drug Resistance in Human Gastric and Colon CancersJapanese Journal of Cancer Research, 1996
- Somatostatin receptor subtype 2 mediates somatostatin inhibition of ion secretion in rat distal colonGastroenterology, 1996
- ATP-Dependent Transport of Lipophilic Cytotoxic Drugs by Membrane Vesicles Prepared from MRP-Overexpressing HL60/ADR CellsBiochemistry, 1996
- Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.Journal of Clinical Investigation, 1995
- Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugsPublished by Elsevier ,1994